AI assistant
HUMANA INC — Director's Dealing 2011
Feb 25, 2011
30145_dirs_2011-02-25_bdbbbe16-3687-4d41-aa83-c160ec57b8cd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HUMANA INC (HUM)
CIK: 0000049071
Period of Report: 2011-02-23
Reporting Person: McCulley Steven E (Vice President & Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-02-23 | Humana Common | M | 11784 | $32.70 | Acquired | 36095 | Direct |
| 2011-02-23 | Humana Common | M | 7709 | $53.96 | Acquired | 43804 | Direct |
| 2011-02-23 | Humana Common | S | 14582 | $63.2427 | Disposed | 29222 | Direct |
| 2011-02-24 | Humana Common | S | 14000 | $62.8225 | Disposed | 15222 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-02-23 | Options | $32.70 | M | 11784 | Disposed | 2012-02-24 | Humana Common (11784) | Direct |
| 2011-02-23 | Options | $53.96 | M | 7709 | Disposed | 2013-02-23 | Humana Common (7709) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Humana Common | 692 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Options | $62.10 | 2014-02-22 | Humana Common (8110) | 8110 | Direct |
| Options | $69.475 | 2015-02-21 | Humana Common (6839) | 6839 | Direct |
| Options | $45.975 | 2015-04-01 | Humana Common (20992) | 20992 | Direct |
| Options | $41.83 | 2016-02-19 | Humana Common (9998) | 9998 | Direct |
| Restricted Stock Units | $ | Humana Common (3879) | 3879 | Direct | |
| Restricted Stock Units | $ | Humana Common (8990) | 8990 | Direct | |
| Phantom Stock Units | $ | Humana Common (7) | 7 | Indirect |
Footnotes
F1: The shares sold in multiple lots ranging from $63.2288 to $63.29 The weighted average sale price was $63.2427
F2: The shares sold in multiple lots ranging from $62.79 to $62.851. The weighted average sale price was $62.8225.
F3: Stock units held for the benefit of reporting person as of January 31, 2011 under the Humana Retirement & Savings Plan including a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, both exempt under Rule 16b-3(c).
F4: Right to buy pursuant to Humana Inc.'s 2003 Stock Incentive Plan.
F5: Incentive and Non-Qualified stock options granted to reporting person on 2/24/05, both vesting in three increments from 2/24/06 to 2/24/08.
F6: Incentive and Non-Qualified stock options granted to reporting person on 2/23/06, NQ options vesting in three increments from 2/23/07 to 2/23/09, and ISO's vesting on 2/23/09.
F7: Incentive and Non-Qualified stock options granted to reporting person on 2/22/07, NQ options vesting in three increments from 2/22/08 to 2/22/10, and ISO's vesting on 2/22/10.
F8: Incentive and Non-Qualified stock options granted to reporting person on 2/21/08, NQ options vesting in three increments from 2/21/09 to 2/21/11, and ISO's vesting on 2/21/11.
F9: Incentive and Non-Qualified stock options granted to reporting person on 4/1/08, NQ options vesting in three increments from 4/1/11 to 4/1/13, and ISO's vesting in two increments on 4/1/12 and 4/1/13.
F10: Reporting person was granted the maximum number of Incentive stock options allowed and remaining options were granted as Non-Qualified stock options. The option grant vests in three increments from 2/19/10 to 2/19/12.
F11: Right to receive one share per restricted stock unit pursuant to the Company's 2003 Stock Incentive Plan.
F12: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
F13: Restricted stock units granted to reporting person on 2/18/10, 100% of the award is vesting on 2/18/13.
F14: Restricted stock units granted to reporting person on 2/17/11, 100% of the award is vesting on 2/17/14.
F15: Phantom Stock Units held for the benefit of reporting person as of January 31, 2011 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Excess Plan exempt under Rule 16b-3(c and d).